Dibiase Mary

Chief Operating Officer

1 company

Strong

Trades Analyzed

12M Win Rate

76.5%

Avg 3M Return

-2.5%

Avg 12M Return

+21.4%

Dibiase Mary is a Chief Operating Officer at X4 Pharmaceuticals, Inc. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $5.0M based on current market prices.

Holdings by Company

XFORFeb 12, 2025

Current Shares1.14M

Value$4.98M

Net Activity-224,290

Bought: 0Sold: 224.3K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 24, 2025	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	22,258	$0.45	$10,094.00	-4.3%	-60.8%	-74.2%
Oct 7, 2024	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	67,695	$0.57	$38,328.91	-13.0%	+40.0%	-78.3%
Sep 9, 2024	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	2,642	$0.66	$1,737.64	-0.9%	-20.6%	-83.6%
Mar 11, 2024	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	15,409	$0.88	$13,590.74	-5.0%	+13.9%	-65.1%
Feb 12, 2024	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	3,683	$1.01	$3,708.78	-1.2%	-4.3%	-54.0%
Nov 1, 2023	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	67,695	$0.73	$49,417.35	-17.9%	+6.8%	-33.4%
Sep 8, 2023	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	2,642	$1.25	$3,299.86	-1.8%	-26.1%	-46.6%
Jun 30, 2023	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	464	$1.89	$876.96	-0.3%	-44.8%	-70.1%
Jun 23, 2023	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	857	$1.93	$1,654.01	-0.6%	-46.4%	-48.5%
Jun 15, 2023	XFOR X4 Pharmaceuticals, Inc	Chief Operating Officer	Sell	857	$2.23	$1,911.11	-0.6%	-47.1%	-55.1%